This compound was also tested for mu-opioid receptor activity, and like conolidine, was discovered to possess no action at the site. Employing exactly the same paw injection examination, a number of alternate options with greater efficacy had been identified that inhibited the First pain response, indicating opiate-like exercise. Supplied the diffe